Zai Lab (ZLAB) EBIT Margin Growth (3y) (2022 - 2026)

Zai Lab (ZLAB) EBIT Margin Growth (3y) (2022 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin Growth (3y) (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 9,942.00
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 530.00
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -1,211.00
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -623.00
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Zai Lab 22.02 Bn 22.02 Bn 61.30 Mn 4,105.00

Historic Data

Download Data
DateValue
Mar 31, 2026 4,105.00
Dec 31, 2025 10,102.00
Sep 30, 2025 18,141.00
Jun 30, 2025 15,499.00
Mar 31, 2025 11,783.00
Dec 31, 2024 43,634.00
Sep 30, 2024 12,669.00
Jun 30, 2024 38,613.00
Mar 31, 2024 104,897.00
Dec 31, 2023 44,275.00
Sep 30, 2023 39,977.00
Jun 30, 2023 63,371.00
Mar 31, 2023 45,296.00
Dec 31, 2022 96,507.00
Sep 30, 2022 110,318.00